Clinical Trial Update: Allogeneic Cord Blood for Neurological Diseases in Adults [EARLY_Phase 1]

View source ↗

Summary

A early-phase clinical trial evaluating allogeneic cord blood for neurological diseases in adults has been withdrawn from the EARLY Phase 1 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury
• Stroke

Drugs mentioned

• Allogeneic cord blood (cord blood)

Snippet

Sponsor: The Medical Pavilion Bahamas | Conditions: Neurological Diseases, Stroke | EARLY_Phase 1 | Status: WITHDRAWN